Phase 3 Readout~month

Phase 3 Topline: Multi-Center, Placebo-Controlled, Phase 3 Study of Etripamil Nasal Spray (NS) in Patients With Atria

Indication
Atrial Fibrillation

Other upcoming events for MIST

Patent ExpiryPatent/Exclusivity Expiry: CARDAMYST

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: Multi-Center, Placebo-Controlled, Phase 3 Study of Etripamil Nasal Spray (NS) in Patients With Atria — MIST Phase 3 Readout | BioSniper